Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 4154
  • 4155
  • 4156
  • …
  • ›
  • »

2026-03-09

Pearson speeds up buyback schedule, reaffirms 2026 ′confidence′

2026-03-09

Clarkson strikes optimistic note for 2026 after profit and sales fall

2026-03-09

GSK inks licensing agreement with Alfasigma, Pan African Resources to acquire Emmerson Resources

2026-03-09

Belgravia Hartford provides corporate update

2026-03-09

Dealings in Securities by Executive Directors of AngloGold Ashanti plc

2026-03-09

Signet Jewelers Reports Preliminary Results for Fourth Quarter and Full Year Fiscal 2026

2026-03-09

Genesis Energy, L.P. Announces Extension of its Revolving Credit Facility and the Opportunistic Repurchase of $110 Million of its Series A Convertible Preferred Units

2026-03-09

Havas Reports the Progress of Transactions Under Its Current Share Buyback Program

2026-03-09

Mullen Group Ltd. Announces Renewal of Normal Course Issuer Bid

2026-03-09

SOLAI Limited Strategically Expands into Personal AI Infrastructure; Outlines Roadmap to Drive the Next Phase of AI Adoption

2026-03-09

ZETA NETWORK GROUP ANNOUNCES REVERSE SHARE SPLIT

2026-03-09

IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE892, a Potential Best-In-Class PRMT5 Inhibitor for MTAP-Deleted Solid Tumors, and Provides MTAP and CDKN2A Pipeline Update

  • «
  • ‹
  • …
  • 4154
  • 4155
  • 4156
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 04/May/2026 22:38:05
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies